Oncological Pharmacy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Emilia Romagna, 47014 Meldola, Italy.
Hospital Pharmacy Unit-CRO Aviano, National Cancer Institute IRCCS, Friuli-Venezia Giulia, 33081 Aviano, Italy.
Curr Oncol. 2024 May 16;31(5):2867-2873. doi: 10.3390/curroncol31050218.
Investigational drug services need to be organised in a structured approach, especially for sites with a large number of ongoing clinical trials. The aim of this study was to develop a tool to assess the complexity of pharmacy involvement in a sponsored oncology clinical trial. Categorisation into ordinal complexity categories was used to assess the complexity of the clinical trials for consistent pharmacy grant applications. The 15 items of the tool were divided into three sections, and individual item scores were agreed upon among four pharmacists with experience in the conduct of clinical trials at two different centres. A final version of the tool, named Pharm-CAT, was approved. The pharmacists were instructed to use Pharm-CAT to assign a score to each new sponsored trial. To determine the cut-offs for the complexity categories, the scores were sorted in ascending order and the cut-offs corresponding to the first and third tertiles of the score distribution were selected. To verify the reproducibility of the results, Pharm-CAT was applied by two pharmacists independently for each trial. Pharm-CAT proved to be user-friendly. Sixty clinical trials were evaluated and a total of 120 scores were recorded. Low-complexity scores ranged from 0 to 19, medium-complexity scores ranged from 20 to 25, and high-complexity scores were 26 or higher. The average score recorded was 22.88 points. Prospective multicentre validation of Pharm-CAT is needed to confirm its applicability.
研究药物服务需要以结构化的方式进行组织,特别是对于正在进行大量临床试验的站点。本研究的目的是开发一种工具,以评估参与赞助肿瘤学临床试验的药房的复杂性。通过分类为有序复杂性类别,评估临床试验的复杂性,以进行一致的药房资助申请。该工具的 15 个项目分为三个部分,并且在两个不同中心进行临床试验的四位经验丰富的药剂师之间达成了对每个项目得分的一致意见。最终版本的工具名为 Pharm-CAT,获得批准。药剂师被指示使用 Pharm-CAT 为每个新的赞助试验分配一个分数。为了确定复杂性类别的截止值,按升序对分数进行排序,并选择分数分布的第一和第三三分位数对应的截止值。为了验证结果的可重复性,两位药剂师分别为每个试验独立应用 Pharm-CAT。Pharm-CAT 被证明易于使用。评估了 60 项临床试验,共记录了 120 个分数。低复杂性分数范围为 0 到 19,中等复杂性分数范围为 20 到 25,高复杂性分数为 26 或更高。记录的平均分数为 22.88 分。需要进行前瞻性多中心验证,以确认 Pharm-CAT 的适用性。